aminoacetonitrile compounds (PharmAust)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameaminoacetonitrile compounds (PharmAust)
Drug Alias Nameaminoacetonitrile compounds (Nihon Nohyaku)monepantel-related compounds (PharmAust)monepantel-related compounds (PharmAust)aminoacetonitrile compounds (PharmAust)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Nerve DegenerationAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNihon Nohyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmAust LtdNihon Nohyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Nerve DegenerationAmyotrophic Lateral Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A